Evidence map›Paper›PMID 35740549›Full record

ArticleCancers2022

Evidence for Recombinant GRP78, CALR, PDIA3 and GPI as Mediators of Genetic Instability in Human CD34+ Cells.

Alice Fabarius, Vanessa Samra, Oliver Drews, Handan Mörz, Miriam Bierbaum, Ali Darwich, Christel Weiss, Susanne Brendel, Helga Kleiner, Wolfgang Seifarth and 4 more

Open access · goldAbstract read
In one paragraph

Article in Cancers, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.4field-weighted citation impact, top 48% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 3 institutions in 2 countries.

Alice FabariusDepartment of Hematology and Oncology, Medical Faculty Mannheim, Heidelberg University, 68167 Mannheim, Germany.ORCID 0000-0001-5976-2876
Vanessa SamraDepartment of Hematology and Oncology, Medical Faculty Mannheim, Heidelberg University, 68167 Mannheim, Germany.
Oliver DrewsBiomedical Mass Spectrometry, Center for Medical Research, Johannes Kepler University, 4020 Linz, Austria.
Handan MörzDepartment of Neurophysiology, Medical Faculty Mannheim, Heidelberg University, 68167 Mannheim, Germany.
Miriam BierbaumDepartment of Radiation Oncology, Medical Faculty Mannheim, Heidelberg University, 68167 Mannheim, Germany.
Ali DarwichDepartment of Orthopedics and Trauma Surgery, Medical Faculty Mannheim, Heidelberg University, 68167 Mannheim, Germany.ORCID 0000-0001-9463-9638
Christel WeissDepartment of Medical Statistics and Biomathematics, Medical Faculty Mannheim, Heidelberg University, 68167 Mannheim, Germany.
Susanne BrendelDepartment of Hematology and Oncology, Medical Faculty Mannheim, Heidelberg University, 68167 Mannheim, Germany.
Helga KleinerDepartment of Hematology and Oncology, Medical Faculty Mannheim, Heidelberg University, 68167 Mannheim, Germany.
Wolfgang SeifarthDepartment of Hematology and Oncology, Medical Faculty Mannheim, Heidelberg University, 68167 Mannheim, Germany.
Wolfgang GreffrathDepartment of Neurophysiology, Medical Faculty Mannheim, Heidelberg University, 68167 Mannheim, Germany.
Wolf-Karsten HofmannDepartment of Hematology and Oncology, Medical Faculty Mannheim, Heidelberg University, 68167 Mannheim, Germany.
Clemens A SchmittDepartment of Hematology and Oncology, Kepler University Hospital, Johannes Kepler University, 4020 Linz, Austria.
Henning D PoppDepartment of Hematology and Oncology, Kepler University Hospital, Johannes Kepler University, 4020 Linz, Austria.ORCID 0000-0003-0090-0204
Heidelberg University · DEJohannes Kepler University of Linz · ATMax Delbrück Center · DE

Funding

Stefan Jentsch Fellowship, Deutsche Gesellschaft für DNA-Reparaturforschung (DGDR) DGDR 11/2020
6 · The paper itself

Abstract

Soluble factors released from irradiated human mesenchymal stromal cells (MSC) may induce genetic instability in human CD34+ cells, potentially mediating hematologic disorders. Recently, we identified four key proteins in the secretome of X-ray-irradiated MSC, among them three endoplasmic reticulum proteins, the 78 kDa glucose-related protein (GRP78), calreticulin (CALR), and protein disulfide-isomerase A3 (PDIA3), as well as the glycolytic enzyme glucose-6-phosphate isomerase (GPI). Here, we demonstrate that exposition of CD34+ cells to recombinant GRP78, CALR, PDIA3 and GPI induces substantial genetic instability. Increased numbers of γH2AX foci (p < 0.0001), centrosome anomalies (p = 0.1000) and aberrant metaphases (p = 0.0022) were detected in CD34+ cells upon incubation with these factors. Specifically, γH2AX foci were found to be induced 4−5-fold in response to any individual of the four factors, and centrosome anomalies by 3−4 fold compared to control medium, which contained none of the recombinant proteins. Aberrant metaphases, not seen in the context of control medium, were detected to a similar extent than centrosome anomalies across the four factors. Notably, the strongest effects were observed when all four factors were collectively provided. In summary, our data suggest that specific components of the secretome from irradiated MSC act as mediators of genetic instability in CD34+ cells, thereby possibly contributing to the pathogenesis of radiation-induced hematologic disorders beyond direct radiation-evoked DNA strand breaks.

Indexed as

CALRCD34+ cellsgenetic instabilitygenotoxic signalingGPIGRP78ionizing irradiationmesenchymal stromal cellsPDIA3

Identifiers

PMID35740549
PMCPMC9221337
OpenAlexW4283445759

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.